Sanofi in Divesture of its Stake in Yves Rocher
July 04, 2012
Cleary Gottlieb is representing Sanofi in connection with the divesture of its direct and indirect stake of approximately 19.3% in the Yves Rocher Group to Société Financière des Laboratoires de Cosmétologie Yves Rocher. Upon closing of the transaction, the Rocher family will control more than 95% of the share capital of the Yves Rocher group. The transaction was announced on July 4.
Sanofi, a global and diversified healthcare leader, acquired a stake in the Yves Rocher group in 1973 and had already divested part of its stake in the early 2000s. This transaction ends the long-standing relationship between Sanofi and the Yves Rocher group.